Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

2.480

-0.140 (-5.34%)

At close: Jun 5, 2026, 4:00 PM EDT

2.590

+0.110 (4.44%)

After-hours: Jun 5, 2026, 7:10 PM EDT

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 5, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Cap	83	136	113	98	173	143
Market Cap Growth	0.91%	20.99%	14.50%	-43.15%	20.77%	186.96%
Enterprise Value	69.14	120.13	91.86	73.73	142.76	107.17
Last Close Price	2.48	4.13	3.50	3.16	5.60	4.77
PS Ratio	-	-	-	468.66	-	279.97
PB Ratio	5.50	8.99	5.64	4.04	5.96	4.04
P/TBV Ratio	5.50	8.99	5.58	4.02	5.86	3.85
EV/Sales Ratio	-	-	-	351.10	-	209.31
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.93	-0.99	-0.98	-0.97	-1.01	-1.00
Net Debt / EBITDA Ratio	1.27	1.28	1.43	2.16	2.13	2.71
Net Debt / FCF Ratio	1.87	2.09	2.69	3.81	4.54	7.18
Asset Turnover	-	0	0	0.01	0	0.02
Quick Ratio	11.49	7.71	8.04	11.89	14.60	28.13
Current Ratio	12.18	8.08	8.54	12.50	14.83	28.35
Return on Equity (ROE)	-74.83%	-67.17%	-60.10%	-38.51%	-43.74%	-61.02%
Return on Assets (ROA)	-70.46%	-62.12%	-58.71%	-39.37%	-41.62%	-57.48%
Return on Invested Capital (ROIC)	-4806.54%	-4756.50%	-5811.34%	-4626.47%	-5036.30%	-6073.92%
Return on Capital Employed (ROCE)	-78.48%	-70.48%	-64.96%	-42.46%	-43.80%	-60.74%
Buyback Yield / Dilution	-1.96%	-3.50%	-2.96%	-2.00%	-6.28%	-28.57%
Total Shareholder Return	-1.96%	-3.50%	-2.96%	-2.00%	-6.28%	-28.57%

SEC Filings: 10-K · 10-Q